Mechanisms of action of repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS)

Psychiatric Annals

Volumn 37, Issue 3, 2007, Pages 181-187

  Richelson, Elliott ^a,b  

^a MAYO CLINIC   (United States)

^b NeuroStar TMS (Transcranial Magnetic Stimulation) System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247549319     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20070301-04     Document Type: Review

References (40)

1. Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry. 2000;48(12);1133-1141.
2. Lomarev M, Denslow S, Nahas Z, Chae JH, George MS, Bohning DE. Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res. 2002;36(4):219-227.
3. Geyer MA, Markou A. Animal models of psychiatric disorders. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995:787-798.
4. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther. 1977;229(2):327-336.
5. Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47(4):379-391.
6. Porsolt RD. Behavioral despair. In: Enna SJ, Malick JB, Richelson E, eds. Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives. New York: Raven Press; 1981:121-139.
7. Cry an JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002;23(5):238-245.
8. Keck ME, Welt T, Post A, et al. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology. 2001;24(4):337-349.
9. Hargreaves GA, McGregor IS, Sachdev PS. Chronic repetitive transcranial magnetic stimulation is antidepressant but not anxiolytic in rat models of anxiety and depression. Psychiatry Res. 2005;137(1-2):113-121.
10. Keck ME, Sillaber I, Ebner K, et al. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci. 2000;12(10):3713-3720.
11. Hausmann A, Schemer C, Hinterhuber H, Humpel C. Chronic repetitive transcranial magnetic stimulation (rTMS) does not affect tyrosine hydroxylase (TH) and dopaminebeta-hydroxylase (DBH) expression in rats in vivo. Synapse. 2002;46(1):45-47.
12. Keck ME, Welt T, Muller MB, et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology. 2002;43(1):101-109.
13. Erhardt A, Sillaber I, Welt T, Muller MB, Singewald N, Keck ME. Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology, 2004;29(11):2074-2080.
14. Kanno M, Matsumoto M, Togashi H, Yoshioka M, Mano Y. Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum. J Neural Sci. 2004;217(1):73-81.
15. Nibuya M, Morinobu S, Duman RS. Regulatontion of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995:15(11):7539-7547.
16. Muller MB, Toschi N, Kresse AE, Post A, Keck ME. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology. 2000;23(2):205-215.
17. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003;54(1):70-75.
18. Lang UE, Bajbouj M, Gallinat J, Hellweg R. Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology (Berl). 2006;187(1):56-59.
19. Yukimasa T, Yoshimura R, Tamagawa A, et al. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry. 2006;39(2):52-59.
20. Krahl SE, Senanayake SS, Pekary AE, Sattin A. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res. 2004;38(3):237-240.
21. Hassert DL, Miyashita T, Williams CL. The effects of peripheral vagal nerve stimulation at a memory-modulating intensity on norepinephrine output in the basolateral amygdala. Behav Neurosci. 2004; 118(1):79-88.
22. Groves DA, Bowman EM, Brown VJ. Recordings from the rat locus coeruleus during acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett. 2005;379(3):174-179.
23. Pridmore S, Belmaker R. Transcranial magnetic stimulation in the treatment of psychiatric disorders. Psychiatry Clin Neurosci. 1999;53(5):541-548.
24. Zwanzger P, Baghai TC, Padberg F, et al. The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychoneuroendocrinology. 2003;28(3):376-385.
25. O'Keane V, Dinan TO, Scott L, Corcoran C. Changes in hypothalamic- pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression. Dial Psychiatry. 2005;58(12):963-968.
26. Cohrs S, Tergau F, Riech S, et al. High-frequency repetitive transcranial magnetic stimulation delays rapid eye movement sleep. Neuroreport. 1998;9(15):3439-3443.
27. Stahl SM. Symptoms and circuits, part 1: major depressive disorder. J Clin Psychiatry. 2003;64(11):1282-1283.
28. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry. 2003;54(5):515-528.
29. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry. 2003;54(5):504-514.
30. Paus T, Castro-Alamancos MA, Petrides M. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci. 2001;14(8):1405-1411.
31. Shajahan PM, Glabus MF, Steele JD, et al. Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(5):945-954.
32. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression, Neuron. 2005;45(5):651-660.
33. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156(5):675-682.
34. Conway CR, Sheline YI, Chibnall JT, George MS, Fletcher JW, Mintun MA. Cerebral blood flow changes during vagus nerve stimulation for depression. Psychiatry Res. 2006;146(2):179-184.
35. Follesa P, Biggio F, Caria S, Gorini G, Marrosu F, Biggio G. Vagus nerve stimulation increases neurotrophins gene expression and alters cell proliferation in the rat hippocampus. Eur Neuropsychopharmacol. 2006;6(Suppl 1):18-19.
36. Duman RS, Nakagawa S, Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 2001;25(6):836-844.
37. Richelson E. Action of antidepressant and other drugs on norepinephrine systems. In: Ordway GA, Schwartz M, Frazer A, eds. Brain norepinephrine. Cambridge: Cambridge University Press; 2007:In press.
38. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ. Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology. 2006;31(8):1745-1749.
39. Keck ME, Engelmann M, Muller MB, et al. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiatr Res. 2000;34(4-5):265-276.
40. Dorr AE, Debonnel G. Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission. J Pharmacol Exp Ther. 2006;318(2):890-898.